Normal human bone marrow CD34+CD133+ cells contain primitive cells able to produce different categories of colony-forming unit megakaryocytes in vitro

This publication has 49 references indexed in Scilit:

• Therapeutic Relevance of CD34 Cell Dose in Blood Cell Transplantation for Cancer Therapy
  Journal of Clinical Oncology, 2000
• Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant
  Bone Marrow Transplantation, 2000
• Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells
  The Lancet, 1999
• Changes in endogenous TPO levels during mobilization chemotherapy are predictive of CD34+ megakaryocyte progenitor yield and identify patients at risk of delayed platelet engraftment post-PBPC transplant
  Bone Marrow Transplantation, 1999
• CD34+/CD41a+ cells best predict platelet recovery after autologous peripheral blood stem cell transplantation
  Bone Marrow Transplantation, 1998
• Quantitation and characterization of human megakaryocyte colony‐forming cells using a standardized serum‐free agarose assay
  British Journal of Haematology, 1997
• CD34⁺cell immunoselection from G-CSF-alone-primed peripheral blood in children with low body mass
  British Journal of Haematology, 1995
• Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation.
  Journal of Clinical Oncology, 1995
• Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphoma
  Blood, 1995
• Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.
  Journal of Clinical Oncology, 1994